Perspective
Neuropsychopharmacology (2004) 29, 1765–1781, advance online publication, 23 June 2004; doi:10.1038/sj.npp.1300506
Discovering Endophenotypes for Major Depression
Gregor Hasler1, Wayne C Drevets1, Husseini K Manji1 and Dennis S Charney1
1Mood and Anxiety Disorders Program, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, USA
Correspondence: Dr G Hasler, Mood and Anxiety Disorders Program, National Institutes of Health, National Institute of Mental Health, 15K North Drive, Room 300C, MSC 2670, Bethesda, MD 20892-2670, USA. Tel: +1 301 594 0234; Fax: +1 301 402 6353; E-mail: g.hasler@bluewin.ch
Received 16 January 2004; Revised 13 April 2004; Accepted 10 May 2004; Published online 23 June 2004.
Abstract
The limited success of genetic studies of major depression has raised questions concerning the definition of genetically relevant phenotypes. This paper presents strategies to improve the phenotypic definition of major depression by proposing endophenotypes at two levels: First, dissecting the depressive phenotype into key components results in narrow definitions of putative psychopathological endophenotypes: mood bias toward negative emotions, impaired reward function, impaired learning and memory, neurovegetative signs, impaired diurnal variation, impaired executive cognitive function, psychomotor change, and increased stress sensitivity. A review of the recent literature on neurobiological and genetic findings associated with these components is given. Second, the most consistent heritable biological markers of major depression are proposed as biological endophenotypes for genetic studies: REM sleep abnormalities, functional and structural brain abnormalities, dysfunctions in serotonergic, catecholaminergic, hypothalamic-pituitary-adrenocortical axis, and CRH systems, and intracellular signal transduction endophenotypes. The associations among the psychopathological and biological endophenotypes are discussed with respect to specificity, temporal stability, heritability, familiality, and clinical and biological plausibility. Finally, the case is made for the development of a new classification system in order to reduce the heterogeneity of depression representing a major impediment to elucidating the genetic and neurobiological basis of this common, severe, and often life-threatening illness.
Keywords:
depression, phenotype, genetics, classification, biological psychiatry, epidemiology
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Oestrogen as a neuroprotective hormone
Nature Reviews Neuroscience Review (01 Jun 2002)
The cellular neurobiology of depression
Nature Medicine Review (01 May 2001)
RESEARCH
Assessment of circadian function in fibroblasts of patients with bipolar disorder
Molecular Psychiatry Original Article
Neuropsychopharmacology Original Article
Molecular Psychiatry Original Article

